Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00119951 · ClinicalTrials.gov registry record
Health eCommunities - The Impact of Listservs on Cancer Patients
A clinical trial, sponsored by Robert Wood Johnson Foundation.
- Completed
- Registry status
- 3,360
- Enrollment target
NCT00119951: Completed study, sponsored by Robert Wood Johnson Foundation.
NCT00119951 is a clinical trial that has completed, run by Robert Wood Johnson Foundation. The registered enrollment target is 3,360 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00119951 has completed, sponsored by Robert Wood Johnson Foundation.
- COMPLETED
- Registry status
- 3,360 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the impact of participation in the Association of Cancer Online Resources (ACOR) mailing lists on chronic disease management for cancer patients, we are focusing on several priority areas. These include factors that influence the use of online interventions over time and the effects of patient-provider interactions on the use of eHealth interventions (as well as vice versa). We also are breaking new ground in a number of important methodological areas related to online survey research. Our specific aims are: 1. Conduct a qualitative analysis of a 10% sample of messages (approximately 5,200) obtained over 5 months from 9 ACOR lists to develop a comprehensive set of potential chronic disease management outcomes and a fuller understanding of the issues and themes that characterize list participation. The content analysis will identify important themes and issues in the messages. These themes and issues will help in survey refinement and ground our proposed quantitative survey questionnaire items. Survey analyses will also be enriched by the qualitative data. Finally, the qualitative analysis will stand as an independent body of work. 2. Conduct a web-based survey of at least 1,680 new ACOR mailing list patient members and approximately 1,680 non-patient subscribers to assess the positive and negative effects of participation in ACOR lists at one month and four months after joining the list and completing a baseline survey. 3. Disseminate study findings to ACOR leadership, participants and the larger online community. 4. Develop a plan to convert the findings into training, recommendations, tools and policies to improve list processes. We aim to answer real world, practical questions using methodology that is at once rigorous, practical and ethical. The components are inter-related and complementary.
Interventions
- BEHAVIORAL Participation on the ACOR Listserv
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,360 participants |
| Start Date | 2003-09 |
| Est. Completion | 2006-08 |
What the finished NCT00119951 record still lists
NCT00119951 is an observational study that tracks outcomes without assigning an intervention. Its 3,360 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Participation on the ACOR Listserv is the first listed.
NCT00119951 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00119951 about?
NCT00119951 is a clinical study titled "Health eCommunities - The Impact of Listservs on Cancer Patients". The purpose of this study is to assess the impact of participation in the Association of Cancer Online Resources (ACOR) mailing lists on chronic disease management for cancer patients, we are focusing on several priority areas. These include factors that influence the use of online interventions ove...
What is the current status of trial NCT00119951?
This trial is currently completed. The enrollment target is 3,360 participants. The study started on 2003-09. Estimated completion is 2006-08.
What interventions are being tested in trial NCT00119951?
The interventions under investigation include: Participation on the ACOR Listserv (BEHAVIORAL).
Who is sponsoring clinical trial NCT00119951?
This trial is sponsored by Robert Wood Johnson Foundation, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06880055 · 3,375 participants
Shield Post-Approval Study Protocol
- NCT03474029 · 3,400 participants · Phase 2
Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI
- NCT07142954 · 3,400 participants · Phase 3
Epidemiology and Biomarker Study in Alzheimer's Disease
- NCT03674307 · 3,306 participants · NA
Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia